Tristan Ferry

OverviewAI-generated summary

Dr. Tristan Ferry's research encompasses a wide range of infectious diseases, with a particular emphasis on orthopedic infections and antimicrobial resistance. Holding a doctorate and the French "Habilitation à Diriger les Recherches" (HDR), he trained in internal medicine and infectious diseases at Hospices Civils de Lyon, France, and furthered his studies in Geneva, Switzerland, focusing on HIV and Staphylococcus aureus bone and joint infections. Dr. Ferry co-heads the Infectious and Tropical Disease unit at Hospices Civils de Lyon and leads the regional reference center for complex bone and joint infections (CRIOAc Lyon). His work includes exploring personalized bacteriophage therapy for antibiotic-resistant bacterial infections and he has recently published on the efficacy of phage therapy in treating pandrug-resistant spinal Pseudomonas aeruginosa infections. He also researches the diagnosis, management, and treatment of infective endocarditis, streptococcal infections, pneumonia, and tuberculosis, and has contributed to COVID-19 research, including studies on remdesivir treatment. Additionally, Dr. Ferry's interests extend to schizophrenia research and treatment.

Metrics

• h-index: 55
• Publications: 540
• Citations: 11,638